Nestle SA, the world's biggest food company, agreed to buy Pfizer Inc's infant-nutrition unit for $11.9 billion, a business that gets most of its sales in fast-growing emerging markets.
The purchase will lead to annual cost benefits of $160 million and will boost earnings per share in the first full year, Nestle CEO Paul Bulcke said Monday in a conference call. The purchase will help the Switzerland-based company, already the top seller of infant-nutrition products, regain traction in the Chinese baby-food market, where it has been losing market share since 2005.??
Agencies - China Daily
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 20100000002731 
